Back to Search Start Over

Duration of Venoarterial Extracorporeal Membrane Oxygenation and Mortality in Postcardiotomy Cardiogenic Shock.

Authors :
Mariscalco G
El-Dean Z
Yusuff H
Fux T
Dell'Aquila AM
Jónsson K
Ragnarsson S
Fiore A
Dalén M
di Perna D
Gatti G
Juvonen T
Zipfel S
Perrotti A
Bounader K
Alkhamees K
Loforte A
Lechiancole A
Pol M
Spadaccio C
Pettinari M
De Keyzer D
Welp H
Maselli D
Lichtenberg A
Ruggieri VG
Biancari F
Source :
Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2021 Sep; Vol. 35 (9), pp. 2662-2668. Date of Electronic Publication: 2020 Nov 05.
Publication Year :
2021

Abstract

Objective: The optimal duration of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients affected by postcardiotomy cardiogenic shock (PCS) remains controversial. The present study was conducted to investigate the effect of VA-ECMO duration on hospital outcomes.<br />Design: Retrospective analysis of an international registry.<br />Setting: Multicenter study including 19 tertiary university hospitals.<br />Participants: Between January 2010 and March 2018, data on PCS patients receiving VA-ECMO were retrieved from the multicenter PC-ECMO registry.<br />Interventions: Patients were stratified according to the following different durations of VA-ECMO therapy: ≤three days, four-to-seven days, eight-to-ten days, and >ten days.<br />Measurements and Main Results: A total of 725 patients, with a mean age of 62.9 ± 12.9 years, were included. The mean duration of VA-ECMO was 7.1 ± 6.3 days (range 0-39 d), and 39.4% of patients were supported for ≤three days, 29.1% for four-seven days, 15.3% for eight-ten days, and finally 20.7% for >ten days. A total of 391 (53.9%) patients were weaned from VA-ECMO successfully; however, 134 (34.3%) of those patients died before discharge. Multivariate logistic regression showed that prolonged duration of VA-ECMO therapy (four-seven days: adjusted rate 53.6%, odds ratio [OR] 0.28, 95% confidence interval [CI] 0.18-0.44; eight-ten days: adjusted rate 61.3%, OR 0.51, 95% CI 0.29-0.87; and >ten days: adjusted rate 59.3%, OR 0.49, 95% CI 0.31-0.81) was associated with lower risk of mortality compared with VA-ECMO lasting ≤three days (adjusted rate 78.3%). Patients requiring VA-ECMO therapy for eight-ten days (OR 1.96, 95% CI 1.15-3.33) and >10 days (OR 1.85, 95% CI 1.14-3.02) had significantly greater mortality compared with those on VA-ECMO for 4 to 7 days.<br />Conclusions: PCS patients weaned from VA-ECMO after four-seven days of support had significantly less mortality compared with those with shorter or longer mechanical support.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1532-8422
Volume :
35
Issue :
9
Database :
MEDLINE
Journal :
Journal of cardiothoracic and vascular anesthesia
Publication Type :
Academic Journal
Accession number :
33250434
Full Text :
https://doi.org/10.1053/j.jvca.2020.11.003